Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 10-K/A, Date: 2011-05-19
Original SEC Filing: Click here

---

Webplus: BSPM/20110519/10-K.A_1/1/000.htm SEC Original: biostarpharma10ka123110.htm
FORM 10-K /A Amendment No. 1 (Mark One) x December 31, 2010 For the fiscal year ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code)

---

---

Webplus: BSPM/20110519/10-K.A_1/2_EX-23.1/000.htm SEC Original: ex23-1.htm
Consent of Independent Registered Public Accounting Firm To the Board of Directors of Biostar Pharmaceuticals, Inc. We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-161598) of Biostar Pharmaceuticals, Inc. of our report dated March 24, 2011 relating to the consolidated financial statements, which appears in the Annual Report on Form 10-K of

---

---

Webplus: BSPM/20110519/10-K.A_1/3_EX-31.1/000.htm SEC Original: ex31-1.htm
CERTIFICATION I, Ronghua Wang, certify that: 1. R I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the

---

---

Webplus: BSPM/20110519/10-K.A_1/4_EX-31.2/000.htm SEC Original: ex31-2.htm
CERTIFICATION I, Zack Pan, certify that: 1. R I have reviewed this Annual 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the

---

---

Webplus: BSPM/20110519/10-K.A_1/5_EX-32.1/000.htm SEC Original: ex32-1.htm
CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 5 ex32-1.htm

---

---

Webplus: BSPM/20110519/10-K.A_1/6_EX-32.2/000.htm SEC Original: ex32-2.htm
CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Zack Pan Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 6 ex32-2.htm

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 10-K/A, Date: 2011-05-19CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046